Whole body-MRI identifies widespread, low intensity inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve, active psoriatic arthritis: Data from the GOLMePsA clinical trial
OBJECTIVES: To describe the prevalence and extent of whole body (WB)-MRI detected joint disease features and their response to therapy in patients with early, active PsA. METHODS: Newly diagnosed PsA patients (treatment-naïve), recruited in GOLMePsA randomized trial (methotrexat…